Second partnership for Fujifilm and Mitsubishi
Fujifilm and Mitsubishi have embarked on a joint business venture in the contract manufacturing for biopharmaceuticals.
EMA OK for second Shire Replagal plant
Shire has received European Medicines Agency (EMA) approval for a new US plant, doubling purification capacity for its Fabry disease drug Replagal.
Appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
DSM adds single-step purification and polishing technique for bioproduction
DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
BioMarin to buy Pfizer’s Shanbally biologics plant
BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
Neuland to launch commercial-scale peptide manufacturing
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Pall expands Allegro mixer range
Processing technology firm Pall Life Sciences has introduced a 200L version of its Allegro single-use mixer for biopharmaceutical manufacturing.
Catalent and Cevec team on cell line development platform
Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
Mystic awarded key manufacturing patent for delivery tech
Mystic Pharmaceuticals has been awarded a US patent for a manufacturing technology that is critical to its biologics delivery platform.
NeoStem’s China antibiotics unit gets expanded SFDA approval
US stem-cell therapy firm NeoStem predicts that output of its China-based generic antibiotics subsidiary Suzhou Erye Pharmaceutical will increase after further manufacturing approval from the SFDA.
SSB and Sudpack team on plastic films for biologics production
Sartorius Stedim Biotech (SSB) has teamed up with packaging firm Sudpack Medica AG in a deal focused on making plastic films for biopharmaceutical industry applications.
Biopharma revenues key to Pall’s Q3 gains
Sales to the biopharmaceutical sector drove revenue growth at Pall in third quarter fiscal 2011 and will be key to the firm’s future says CEO.
Unilife says device selected for new biologic trial
Unilife says its one of its technologies has been selected as the delivery device for a biologic drug in an upcoming clinical trial.
Lonza announces CHF10m Singapore biomanufacturing expansion
Switzerland-based life sciences supplier Lonza says it will invest CHF10m (€8m) to expand a Singapore plant that is part of its custom biomanufacturing business.
Xcellerex wins new customers for manufacturing techs
Biomanufacturing technology firm Xcellerex has had a good start to June with R-Pharm and Fujifilm Diosynth signing up as customers.